Press Releases from Onyx Scientific Ltd (11 total)

Leading chemistry services organisation, Onyx Scientific Ltd, is pleased to announce an increased demand for its early-phase, GMP synthesis, Investigational New Drug (IND) services for the development of Active Pharmaceutical Ingredients (APIs). “At Onyx we plan for success by focussing on detail” explains CEO Tony Flinn. “Our service driven systems deliver comprehensive chemical route development, efficient raw materials sourcing, thorough analysis and world-class solid-state characterization. We are recognised as the…

Onyx Scientific, a trusted global chemistry services CRO and leading provider of high justified intermediates and APIs for both phase I and phase II clinical studies, hails the success of its world-class solid-state polymorph screening services for the increased demand for its international GMP-compliant Process Development capability. Onyx Scientific specialise in Medicinal Chemistry, Process Development, Custom Synthesis, GMP synthesis and Scale-up, in addition to a comprehensive range of Analytical and…

Experts in the provision of solid-state chemistry services for the pharmaceutical and biotech industries, leading global contract research organisation, Onyx Scientific, is delighted to report increased demand in taking candidate compounds from concept through to process development and scale-up of APIs for Phase I and Phase II clinical studies. “Handling difficult-to-crystallize materials is an art form as well as a science” explains Tony Flinn, CEO, Onyx Scientific. “Inherently complicated, the implications…

Internationally renowned, contract research organisation Onyx Scientific, is pleased to announce the continued growth of its small-scale GMP custom synthesis services for development APIs (Active Pharmaceutical Ingredients) Commenting on the growing success of its small-scale GMP synthesis services, CEO, Dr Tony Flinn says “our success is due to open communication and a highly responsive scientific team, who are able to lower the cost of a GMP process by…

Polymorph screening specialists, Onyx Scientific Ltd – chemistry outsourcing partner to the pharma and biotech industries – today announced the record-breaking growth of its solid-state chemistry services for the discovery, analysis and scale-up of polymorphs, hydrates, amorphous phases, salts and co-crystals of Active Pharmaceutical Ingredients (APIs). In close partnership with an international client base and often working with just a few grams of precious API material, Onyx Scientific performs highly specific…

Due to continued growth of the company’s services to Pharmaceutical and biotech companies Onyx Scientific has appointed Dr Enrico Grassi to cover mainland Europe. “These are important biotech areas for Onyx Scientific’s services and a local contact as experienced as Enrico will undoubtedly enhance our capabilities in these areas” commented Denise Bowser, Commercial Director at Onyx Scientific. Enrico has over 24 years experience in drug discovery services and a PhD…

Onyx Scientific Ltd Receives French Research Tax Credit Accreditation Onyx Scientific Ltd, the Contract Chemistry R&D Company is pleased to announce that it has received French research tax credit approval. The French Ministry of Research (Ministère de l'Enseignement Supérieur et de la Recherche) has granted the French R&D tax credit ("Crédit d'Impôt Recherche", CIR) accreditation to Onyx Scientific as of June 2010. This initiative allows eligible French pharmaceutical, biotech and agricultural companies…

Onyx Scientific Ltd, the premier provider of outsourcing chemistry services, credits its problem-solving Process Development expertise and custom organic synthesis capability for its growing reputation as the preferred chemistry services provider within the custom synthesis market. A research-driven and customer-focused company, Onyx Scientific provide pharmaceutical and biotechnology companies a broad and integrated portfolio of contract chemistry services throughout the drug discovery and development process, services that include: Process Development, Custom Synthesis,…

Internationally renowned, contract research organisation Onyx Scientific, is pleased to announce the growth of its GMP synthesis services for development stage APIs (Active Pharmaceutical Ingredients). Good manufacturing practice (GMP) compliance is an international requirement for the manufacture of medicinal products for human and veterinary use. Compliance ensures medicinal products are produced safely and correctly. Among the first of its type to be approved by the UK Medicines and Healthcare Products Regulatory Agency…

Following a major round of capital expenditure, the UK based contract research organisation, Onyx Scientific Ltd, is pleased to announce the rapid growth of its highly successful solid-state, polymorph screening chemistry services, launched in 2008. Equipped with the latest X-Ray Powder Diffraction and Raman Spectroscopy instrumentation, for automated 96 well format sample preparation, this new solid-state laboratory positions Onyx-Scientific as a preferred outsourcing provider for rapid, solid-form polymorph investigation, salt…

Following a major round of capital expenditure, the UK based contract research organisation, Onyx Scientific Ltd, is pleased to announce the highly successful launch of its solid-state research and development services offering to the pharmaceutical industry. Equipped with the latest X-Ray Powder Diffraction and Raman Spectroscopy instrumentation, for automated 96 well format sample preparation, this new solid-state laboratory positions Onyx-Scientific as a preferred outsourcing provider for rapid, solid-form polymorph investigation,…